Home | Symbol Index | About |

Antisoma (London) (AIOAF) > Trackbacks

Antisoma plc: Antisoma announces positive phase I data on AS1411, plans phase II trials in renal and blood cancers

Mon, 2 Oct 2006 0:10:00 PDT

LONDON and ISTANBUL, TURKEY (MARKET WIRE) Antisoma today announces the presentation of positive phase I results for its aptamer drug AS1411. Findings in renal cancer are particularly strong. Antisoma will therefore proceed to a phase II trial in this indication. Antisoma will also initiate a phase II trial in a blood cancer indication. Both trials are expected to start in 2007.

Trackbacks

A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to Antisoma plc: Antisoma announces positive phase I data on AS1411, plans phase II trials in renal and blood cancers.


What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.




Powered by Odin Assemble 2.5a